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Abstract
Aims/hypothesis FTO harbours the strongest known
obesity-susceptibility locus in Europeans. While there is
growing evidence for a role for FTO in obesity risk in
Asians, its association with type 2 diabetes, independently
of BMI, remains inconsistent. To test whether there is an
association of the FTO locus with obesity and type 2
diabetes, we conducted a meta-analysis of 32 populations
including 96,551 East and South Asians.
Methods All studies published on the association between
FTO-rs9939609 (or proxy [r2>0.98]) and BMI, obesity or
type 2 diabetes in East or South Asians were invited. Each
study group analysed their data according to a standardised
analysis plan. Association with type 2 diabetes was also
adjusted for BMI. Random-effects meta-analyses were
performed to pool all effect sizes.
Results The FTO-rs9939609 minor allele increased risk of
obesity by 1.25-fold/allele (p=9.0×10−19), overweight by
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1.13-fold/allele (p=1.0×10−11) and type 2 diabetes by 1.15-
fold/allele (p=5.5×10−8). The association with type 2
diabetes was attenuated after adjustment for BMI (OR 1.10-
fold/allele, p=6.6×10−5). The FTO-rs9939609 minor allele
increased BMI by 0.26 kg/m2 per allele (p=2.8×10−17),
WHR by 0.003/allele (p=1.2×10−6), and body fat percent-
age by 0.31%/allele (p=0.0005). Associations were similar
using dominant models. While the minor allele is less
common in East Asians (12–20%) than South Asians (30–
33%), the effect of FTO variation on obesity-related traits
and type 2 diabetes was similar in the two populations.
Conclusions/interpretation FTO is associated with increased
risk of obesity and type 2 diabetes, with effect sizes similar in
East and South Asians and similar to those observed in
Europeans. Furthermore, FTO is also associated with type 2
diabetes independently of BMI.
Keywords Asians .FTO . Meta-analysis . Obesity . Type 2
diabetes
Abbreviations
GWAS Genome-wide association study
MAF Minor allele frequency
PAR Population-attributable risk
SNP Single-nucleotide polymorphism
Introduction
Large-scale genome-wide association studies (GWAS) in
mainly white Europeans have identified at least 50 genetic
loci to be robustly associated with obesity-related traits [1–
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12]. A cluster of common variants in the first intron of the
fat mass and obesity-associated gene (FTO) was the first
obesity-susceptibility locus to be identified by two inde-
pendent GWAS in 2007 [1, 2] and has since been
consistently replicated by many others and for a variety of
obesity-related traits [7, 9, 13–15]. Of all currently
identified obesity-susceptibility loci, the FTO locus has
the most pronounced effect on BMI and obesity risk, at
least in individuals of European descent. Each minor allele
of any commonly investigated variant in FTO increases
BMI by 0.30–0.40 kg/m2 (equivalent to 870–1,150 g for a
person 1.7 m tall) and risk of obesity by ∼20% [7, 15]. The
minor allele of the FTO variant is common (minor allele
frequency (MAF)=∼42%) in white Europeans, such that
66% of Europeans carry at least one risk allele and 18%
carry two risk alleles. Because of the high prevalence of the
risk allele and its relatively strong effect on BMI, the FTO
locus explains most (0.34%), yet little, of the variation in
BMI in Europeans [7].
FTO has also been examined as an obesity-susceptibility
locus in populations of non-white European origin. While
the initial replication efforts in East Asian populations were
inconsistent [16, 17], a growing number of studies have
provided evidence that genetic variation in FTO influences
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BMI and obesity risk also in Chinese, Japanese, Korean and
Filipino populations [18–27]. A GWAS for BMI in 7,861
Koreans identified variation in FTO (rs9939609) as the
most significantly associated locus, nearly reaching
genome-wide significance (p=1.5×10−7) [28]. Further-
more, literature-based meta-analyses in Asians reported
that the minor allele for the rs9939609 FTO single-
nucleotide polymorphism (SNP) significantly (p=9×10−9)
increased the risk of obesity, but no other obesity-related
traits were examined [18, 29, 30]. Fewer studies in South
Asians have been reported, two of which confirmed the
association between the FTO locus and obesity susceptibility
[31, 32], whereas one did not [33]. The prevalence of the risk
allele in East Asians (∼20%) and South Asians (∼30%) is
substantially lower than in Europeans, and the reported effect
sizes in both East and South Asians vary widely for BMI
(OR 0.13–0.83 kg/m2 per minor allele) and obesity risk (OR
1.02–1.48 per minor allele) [16, 18, 20–25, 27, 34–39].
FTO was first identified as a type 2 diabetes-
susceptibility gene, but, as further adjustment for BMI
abolished the association with type 2 diabetes [1], it was
suggested that FTO is primarily an obesity-susceptibility
locus. However, the BMI-independent role of FTO in type 2
diabetes remains a matter of debate, particularly in Asians
but also in white Europeans. While several studies have
reported that the association between the FTO locus and risk
of type 2 diabetes remained significant after adjustment for
BMI [15, 18, 33, 35, 40, 41], others could not confirm this
[21, 30, 32, 37, 42].
To firmly establish the association between the FTO
locus and obesity susceptibility in East and South Asians
and to assess its effect size and potential heterogeneity
across Asian populations, we performed a systematic meta-
analysis of data from 32 populations, including 96,551 men
and women, using standardised study-specific association
analyses. Furthermore, we examined whether the FTO
locus is associated with type 2 diabetes independently of
its association with BMI.
Methods
Literature search and study identification We designed a
meta-analysis based on de novo analyses of data according
to a standardised plan to achieve the greatest consistency
possible across studies. We identified all published studies
(before September 2010) that had examined the association
of genetic variation in FTO with risk of obesity and type 2
diabetes and with obesity-related continuous traits in East
and South Asian adults (age ≥18 years) by a PubMed
literature search using the key words ‘FTO’, ‘fat mass and
obesity associated gene’ and ‘genome-wide association
study’. References from the identified papers were subse-
quently screened to identify additional studies and to ensure
that the list of eligible studies was complete. The literature
search was carried out by two investigators independently,
who cross-checked their search results for completeness.
Our literature search identified 38 publications, one of
which was excluded because it was a subsample of another
identified study. We invited the corresponding authors of
the remaining 37 publications to join our meta-analysis, of
which 26 agreed to participate and eventually 22 submitted
raw data or summary statistics. We also included a Korean
population with previously unpublished data (Y. M. Kim,
J. Shin, C.B. Lee, M.K. Kim, Y. Tabara, T. Miki and B.Y.
Choi), which was presented by a contributing author.
Taken together, our meta-analysis included data for 31
populations from 22 publications and one unpublished
study, with 96,551 individuals altogether. The study
identification and selection process is illustrated in Fig. 1.
All studies were conducted according to the Declaration
of Helsinki. Informed consent was obtained from all
participants, and the studies were approved by the ethics
committees of the participating institutions.
Genotyping The rs9939609 FTO SNP was examined in 18
studies, whereas proxy SNPs were used in 14 studies. More
specifically, the rs8050135 SNP was genotyped in 11
studies of East Asians and one of South Asians, and the
rs3751812 and rs17817449 SNP were each genotyped once
in studies of East Asians (electronic supplementary material
[ESM] Table 1). The linkage disequilibrium between
rs9939609 and the three proxies (rs8050135, 3751812,
rs17817449) is perfect (r2=1) in populations of East Asian
origin, based on CHB+JPT data from the HapMap (Rel 24/
Phase II). The linkage disequilibrium between rs9939609
and rs8050135 in Indian Asians is very high (r2>0.98),
based on a subsample (n=305) of the participating Lolipop
study.
The genotyping success rate and concordance rate
were >95%, and genotype distributions were in Hardy–
Weinberg equilibrium (p>0.01) in all participating studies
(ESM Table 1).
Statistical analysis As case–control definitions and statistical
analyses used in the published papers were inconsistent,
we asked analysts of each of the participating cohorts to
re-analyse their data according to a standardised analysis
plan. Summary statistics of each study were subsequently
meta-analysed.
Obesity-susceptibility traits and type 2 diabetes Over-
weight was defined as a BMI ≥24 kg/m2, and obesity as a
BMI ≥28 kg/m2 according to the definition proposed by the
Working Group on Obesity in China [43]. Anthropometric
data, including weight, height, waist circumference, hip
984 Diabetologia (2012) 55:981–995
circumference and body fat percentage, were collected in
each study as described previously (ESM Table 1), BMI
was calculated as weight (kg) divided by height squared
(m2), and WHR as waist circumference (cm) divided by hip
circumference (cm). Raw data were used for analyses.
Type 2 diabetes was defined as meeting one or more of
the following criteria: (1) fasting glucose ≥7.0 mmol/l;
(2) 2-h glucose ≥11.1 mmol/l; (3) previous diagnosis of
type 2 diabetes; (4) HbA1c ≥6.5% (48 mmol/mol); (5) self-
reported type 2 diabetes (ESM Table 1).
Study-specific de novo data analyses Association analyses
within each study were performed for the total population
and for men and women separately using additive and
dominant genetic models. The associations of FTO-
rs9939609 (or proxy) with risk of obesity and type 2
diabetes were assessed with multiple logistic regression
models. Generalised linear models were used to assess the
associations of FTO-rs9939609 (or proxy) with obesity-
related continuous traits. In studies with a case–control
design, analyses for continuous traits were conducted in
control samples only. All analyses were adjusted for age
and sex (sex-stratified analyses were only adjusted for age).
The association with type 2 diabetes was also analysed with
adjustment for BMI. Adjustments were performed by
including the covariates (age, sex and/or BMI) as a linear
term in the association model.
Summary statistics from the study-specific association
analyses were reported in a standardised Excel form by
the analysts of each study and collected centrally for
meta-analyses.
Meta-analyses Data extraction from the forms and meta-
analyses was performed independently by two investigators
and cross-checked for consistency. All ambiguities were
clarified with the respective analysts before the final
meta-analyses.
ORs and beta coefficients from the individual studies
were pooled using DerSimonian and Laird random-effects
meta-analyses [44]. Meta-analyses were performed of all
studies combined. Because of differences in genetic
background as well as in susceptibility to obesity and type 2
diabetes, meta-analyses were also stratified by East Asian
and South Asian origin of the populations. Furthermore,
East Asians were further stratified according to their
country of origin.
Between-study heterogeneity was tested by Cochrane’s
Q test and quantified by the I2 index. I2 values of <25%,
25–75% and >75% were defined as low, moderate and high
heterogeneity, respectively [45]. To examine the sources of
Potentially relevant studies identified by a
literature search and screened for retrieval (n=49)
Inclusion criteria:
•Asian population 
•Published in English before Aug 2010
•Association study
Studies excluded: in children or 
adolescents (n=4), other phenotypes
(n=6), in Asian Americans (n=1)
Studies retrieved for more detailed evaluation
(n=38)
Studies excluded: duplication (n=1)
Potential studies to be included in the meta-
analyses (n=37) 
Authors contacted by email to request raw or 
summary data 
No reply (n=11)
Reply, data unavailable (n=4)
Included in meta-analyses:
22 published studies of which 3 raw datasets and 
19 summary datasets
1 unpublished study
Fig. 1 Study identification and
inclusion in the meta-analyses
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heterogeneity in our meta-analyses, we performed random-
effects meta-regressions, where the between-study variance
was estimated with the restricted maximum likelihood
approach. Meta-regressions included the following study-
specific variables as covariates: year of publication, country
of origin, sample size, study design, mean age and mean
BMI.
A funnel plot, along with Begg’s and Egger’s tests, was
used to test for the presence of publication bias.
Statistical analyses were performed with the Stata 9.0
software (StataCorp LP, College Station, TX, USA). Meta-
analyses and meta-regressions were implemented by the
metan and metareg commands of Stata, respectively. p<
0.05 was considered to be significant, except for
Cochrane’s Q test for heterogeneity and Begg’s and Egger’s
tests for publication bias, where a level of p<0.10 was used.
The variation in obesity-related continuous traits
explained by the FTO variant was evaluated using the
equation 2f(1−f )a2, where f is the frequency of the variant
and a is its additive standardised effect [5]. Population-
attributable risk (PAR) was calculated as PAR ¼
ðX  1Þ=X . Assuming a multiplicative model, X ¼
1 fð Þ2 þ 2f 1 fð Þg þ f 2g2, where γ is the estimated
OR, and f is the frequency of risk allele [46].
Results
Characteristics of populations included in the meta-
analyses Analyses were conducted in Chinese Hans (China
Mainland: n=10; Singapore: n=2), Japanese (n=7), Indians
(n=7), Koreans (n=4), Singapore Malays (n=1) and
Filipinos (n=1; Table 1). Fifteen of the populations were
case–control designed for obesity (n=3) or type 2 diabetes
(n=8) or both (n=4), whereas 17 populations were
population-based. The mean age and BMI of the popula-
tions ranged from 27.9 to 66.8 years and from 20.5 to
27.1 kg/m2, respectively. The prevalence in population-
based studies ranged from 3.1% to 37.9% for obesity and
from 2.9% to 41.9% for type 2 diabetes.
The MAF of FTO-rs9939609 (or proxy) is 12–14% in
Chinese Hans and Koreans, 18–20% in Japanese and
Filipinos, and 30–33% in Singapore Malays and Indians
(Table 1).
Associations with obesity and overweight A total of 24
populations (nobese=13,032; noverweight=22,474; nnormalweight=
35,767) were available for meta-analyses of the association
between the FTO variant and risk of obesity and overweight.
Each additional FTO-rs9939609 minor (A) allele in-
creased the odds of obesity by 1.25 (p=9.0×10−19)
compared with normal weight individuals (Fig. 2), and by
1.17 (p=7.4×10−11) compared with non-obese individuals
(ESM Fig. 1). Each additional minor allele increased the
odds of overweight by 1.13 (p=1.0×10−11; ESM Fig. 2).
The odds of obesity and overweight were the same in both
East Asian and South Asian populations (p=0.18 and 0.84,
respectively; ESM Table 2). Associations were similar in
men and women (ESM Table 3). The heterogeneity across
all studies was low (13%≤I2≤19%).
When a dominant genetic model was used, the odds
were only slightly higher than for the additive genetic
model (ESM Table 4).
Association with type 2 diabetes In our meta-analysis of 22
populations (ncases=33,744, ncontrols=43,549), each addi-
tional FTO-rs9939609 minor allele increased the odds of
type 2 diabetes by 1.15 (p=5.5×10−8) when adjusted for
age and sex (Fig. 3). Further adjustment for BMI
attenuated, but did not abolish, the association with type 2
diabetes (OR 1.10, p=6.6×10−5) (Fig. 4). Results were
similar in East Asians and South Asians (ESM Table 2), in
men and women (ESM Table 3), and when a dominant
model was used (ESM Table 4).
The association results across all studies showed
moderate heterogeneity (44%≤I2≤48%; Figs 3 and 4).
Meta-regression analyses revealed that the difference in
study design contributed to some of the heterogeneity.
Subsequent subgroup analyses showed that the association
with type 2 diabetes was more pronounced in studies with a
case–control design (OR [95% CI]=1.19 [1.14, 1.23], p=
3.7×10−19, I2=0.0%) than in cohort studies (OR [95% CI]=
1.09 [0.99, 1.20], p=0.07, I2=54.4%), which showed
moderate heterogeneity (ESM Table 5).
Associations with obesity-related continuous traits The
meta-analyses of the association of FTO-rs9939609 with
BMI, waist circumference, hip circumference, WHR
and body fat percentage included 30 (n=71,022), 22
(n=51,543), 20 (n=48,508), 20 (n=48,508) and nine
(n=19,580) populations, respectively.
Each additional FTO-rs9939609 minor allele was asso-
ciated with a 0.26 kg/m2 higher BMI (p=2.8×10−17;
equivalent to ∼750 g/allele for a person 1.7 m tall)
(Fig. 5), 0.51 cm larger waist circumference (p=3.0×10−9)
(ESM Fig. 3), 0.36 cm larger hip circumference (p=0.0003)
(ESM Fig. 4), 0.003 greater WHR (p=1.2×10−6; ESM
Fig. 5), and 0.31% higher body fat percentage (p=0.0005)
(ESM Fig. 6). All associations were very similar between
East and South Asians (ESM Table 2), between men and
women (ESM Table 3), or when a dominant genetic model
was used (ESM Table 4).
We observed moderate heterogeneity across studies in the
associations with BMI and hip circumference (BMI: I2=33%;
hip circumference: I2=51%; Fig. 5; ESM Fig. 4). Meta-
regression suggested that, for BMI, the heterogeneity was
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mainly due to difference in mean age and mean BMI among
different populations. For hip circumference, the heteroge-
neity was mainly attributed to difference in mean BMI, i.e.
the effect of the FTO minor allele tended to be larger in
populations with a mean BMI ≥24 kg/m2, compared with
those with a mean BMI <24 kg/m2.
FTO-rs9939609 explained 0.16% and 0.20% of the
inter-individual variation in BMI in East and South Asian
populations, respectively. The proportion of variation in
other obesity-related continuous traits explained by
FTO-rs9939609 was <0.10% (ESM Table 2).
Publication bias The funnel plots for the associations with
obesity, type 2 diabetes, waist circumference, WHR and
body fat percentage were symmetrical and the results for
Begg’s and Egger’s tests were non-significant (p≥0.10),
indicating that our results were not affected by publication
bias (ESM Fig. 7). However, there was some evidence of
publication bias and/or genetic heterogeneity for BMI
(Begg’s test, p=0.08; Egger’s test, p=0.07) and hip
circumference (Begg’s test, p=0.03; Egger’s test, p=0.08;
ESM Fig. 7).
Discussion
This meta-analysis, combining data of 96,551 Asians from
32 populations, further confirms that genetic variation in
FTO is associated with increased risk of obesity in East and
South Asians. Despite differences in genetic background
and obesity susceptibility between East and South Asians,
the effect of FTO on obesity and related traits was generally
East Asians
Chinese Hans (case=3,994, control=11,205)
Weight (%)OR (95% CI)
GSBC [55]
WDS [35]
1.57 (0.97, 2.53)
1.93 (0.70, 5.35)
1.0
0.2
SP2 [22]
SDCS [22] 
1.02 (0.71, 1.45)
1.25 (0.93, 1.67)
1.8
2.6
Chang et al., 2008 [23] 
CRISPS [24] 
Liu et al., 2010 [18]
1.48 (1.15, 1.91)
1.40 (1.05, 1.87)
1.32 (1.02, 1.72)
3.3
2.6
3.1
NHAPC [16]
CUHK [21]
1.01 (0.79, 1.28)
1.29 (1.13, 1.48)
3.7
8.6
Pooled p = 2.24 × 10−7 (I  = 7.6%)
Japanese (case=3,056, control=15,875)
1.27 (1.16, 1.39) 26.9
CAGE-BMI Study [59]
Takahata Study [19]
1.04 (0.77, 1.39)
1.47 (1.17, 1.84)
2.5
3.9
CAGE-Amagasaki Study [59]
CAGE-Fukuoka Study [59]
1.22 (1.02, 1.47)
1.17 (1.03, 1.34)
5.6
8.8
Pooled p = 7.24 × 10−5 (I  = 57.7%) 
GWASJPN-Obesity [20]
1.28 (1.13, 1.45)
1.46 (1.29, 1.65)
30.3
9.5
Korean (case=652, control=2,141)
Cha et al., 2009 [58] 0.82 (0.44, 1.54) 0.6
Cha et al., 2007 [25]
Pooled p = 0.43 (l  = 51.5%)
YangPyeung Cardiovascular Cohort Study
1.43 (1.07, 1.92)
1.13 (0.84, 1.45) 
1.02 (0.78, 1.32)
2.5
6.2
3.1
Singapore Malay (case=848, control=846)
SiMES [22] 1.25 (1.03, 1.52) 5.0
p = 0.03
Filipino women (case=321, control=836)
CLHNS [27] 1.46 (1.16, 1.85) 3.8
p = 0.001
East Asians:  p = 1.17×10−13 (l  = 28.0%) 1.27 (1.19, 1.36) 72.2
Indian (case=4,161, control=4,874)
South Asians
SINDI [22]
PMNS [33]
Parthenon [33]
1.16 (0.97, 1.39)
1.17 (0.80, 1.71)
1.29 (0.97, 1.69)
5.8
1.6
2.8
LOLIPOP-IA510 [6]
LOLIPOP-IA317 [6]
1.19 (1.08, 1.32)
1.15 (0.96, 1.38)
11.8
5.8
Pooled p = 9.04×10−6 (l  = 0.0%) 1.18 (1.10, 1.28) 27.8
p overall = 9.00×10−19 (l  = 18.9%) Overall OR (95% Cl) =1.25 (1.19, 1.31)
420.50.25 1
2
2
2
2
2
2
Fig. 2 Association of FTO-rs9939609 (or proxy) with obesity. Study-
specific association analyses assumed an additive genetic model,
comparing obese with normal-weight individuals, adjusted for age and
sex. Effect sizes were combined using random-effects meta-analyses
(DerSimonian–Laird method)
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similar to, or only somewhat smaller than, those reported
for white Europeans. We furthermore confirm that variation
in FTO is associated with increased risk of type 2 diabetes,
an association that, unlike in white Europeans, is not
abolished after adjustment for BMI in both East and South
Asians.
Large-scale studies in individuals of white European
descent have reported that each additional FTO minor allele
increases the odds of obesity by 1.20–1.32-fold [1, 5, 7,
47]. The association with obesity observed in Asians in the
present study was remarkably similar, with each additional
minor allele increasing obesity risk by 1.25-fold (95% CI
1.19, 1.31), consistent with the association observed for
obesity in previous literature-based meta-analyses of case–
control studies in East and South Asians [18, 29, 30].
The association of the FTO variant with overweight was
the same in East and South Asians (OR 1.13 per minor
allele) and very similar to the effects (ORs ranging from
1.13 to 1.18) that have been reported in large-scale studies
of white Europeans [1, 7, 47]. While the effect sizes
observed for the influence of FTO on obesity and
overweight in Asians are very similar to those of Europeans,
it should be noted that the definitions of obesity and
overweight are different, as BMI cut-offs are somewhat lower
in Asians than in Europeans, consistent with the association of
BMI with metabolic disease [48].
The FTO minor allele increases BMI by 0.26 kg/m2
(equivalent to ∼750 g/allele for a person 1.7 m tall) in
Asians, with very similar results for East and South Asians.
This observation suggests that the effect of FTO on BMI in
Asians is substantially smaller than the effect observed in a
meta-analysis of more than 125,000 white Europeans
(0.39 kg/m2 per minor allele, or 1,130 g per minor allele)
[7]. This difference may be due to the fact that BMI in
East Asians OR (95% CI) Weight (%)
Chinese Hans (case=13,927, control=14,432)
1.73 (0.91, 3.28) 0.6
0.93 (0.73, 1.18)
1.42 (1.17, 1.73)
0.78 (0.55, 1.11)
3.0
4.1
1.7
1.20 (0.99, 1.45)
0.99 (0.82, 1.19)
1.11 (0.94, 1.29) 
4.3
4.4
5.2
WDS [35]
NHAPC [16]
CUHK [21]
SP2 [22]
FLSGS [57]
Chang et al., 2008 [23]
SGWAS [42]
SHDS [56]
Liu et al., 2010 [18]
1.13 (0.97, 1.30)
1.20 (1.04, 1.39)
5.8
5.8
Japanese (case=11,580, control=11,875)
1.12 (1.02, 1.24) 34.9
RIKEN T2D Study [37]
Takahata Study [19]
1.23 (1.10, 1.38)
1.08 (0.85, 1.37)
7.3
3.1
CAGE-T2DM [59] 1.19 (1.12,1.26)
1.19 (1.13, 1.25)
9.8
20.2
YangPyeung Cardiovascular Cohort Study
Korea SNUH [34]
Korean (case=952, control=2,690)
1.10 (0.80, 1.50)
1.16 (0.92, 1.48)
2.0
3.1
1.14 (0.94, 1.38) 5.1
Singapore Malay (case=787, control=1,248)
p = 0.23
SiMES [22] 1.10 (0.94, 1.29) 5.3
Filipino women (case=155, control=1,463)
CLHNS [27] 1.64 (1.25, 2.16) 2.5
p = 0.0004
1.15 (1.09, 1.22) 68.0
Indian (case=6,271, control=11,841)
South Asians
1.57 (1.06, 2.34)
WELLGEN [33]
PMNS [33]
SINDI [22]
1.18 (1.02, 1.37)
1.11 (0.96, 1.28)
5.6
1.4
5.8
LOLIPOP-IA610 [6]
Sikh Diabetes Study [40]
LOLIPOP-IA310 [6]
1.00 (0.92, 1.09)
1.24 (1.08, 1.42)
1.07 (0.91, 1.27)
8.4
6.0
4.8
1.13 (1.03, 1.24) 32.0
Overall OR (95% CI) = 1.15 (1.09, 1.21)
0.25 0.5 1 2 4
Pooled p = 0.02 (I  = 52.7%)2
Pooled p = 1.57×10−11(I   = 0.0%) 2
East Asians: p = 2.43×10−7(I   = 40.0%)2
p overall  = 5.48×10−8 (I  = 48.4%)2
Pooled p = 0.01 (I   = 54.6%) 2
Pooled p = 0.18 (I   = 0.0%) 2
Fig. 3 Association of FTO-rs9939609 (or proxy) with type 2 diabetes. Study-specific association analyses assumed an additive genetic model
adjusted for age and sex. Effect sizes were combined using random-effects meta-analyses (DerSimonian–Laird method)
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Asians does not represent exactly the same adiposity
phenotype as in Europeans. However, given that other
large-scale studies in white Europeans have reported effects
for FTO on BMI that range between 0.26 and 0.39 kg/m2,
the comparison between Asians and Europeans should be
made with caution [1, 3, 5, 15, 47]. The FTO variant also
showed convincing association with measures of fat
distribution such as waist and hip circumference and
WHR in Asians. Despite the often described difference in
abdominal obesity between East and South Asians, the
effect sizes were very similar in the two groups. Consistent
with the observations for BMI, the effect sizes tended to be
somewhat smaller than those reported for white Europeans.
For example, each additional FTO minor allele increased
waist circumference by 0.51 cm in Asians, whereas large-
scale studies in Europeans have reported an increase of
0.73–1.00 cm [1, 9, 47].
As the MAF of the FTO variant is substantially lower in
Asians (East Asians, ∼17%; South Asians, ∼32%) than in
white Europeans (∼45%), and as the effect of this allele on
obesity-related traits is similar or somewhat lower in Asians
than in white Europeans, the overall contribution of genetic
variation in FTO to obesity susceptibility will be lower in
Asians, in particular East Asians. For example, the FTO
variant explained less of the inter-individual variation in
BMI in Asians (East Asians, 0.16%; South Asians, 0.20%)
than in white Europeans (0.34%) [7]. Furthermore, the low
risk allele frequency led to a lower PAR for the risk of
obesity (East Asians, 8.3%; South Asians, 10.6%) and
overweight (East Asians, 4.1%; South Asians, 7.8%) in
Asians than in white Europeans (obesity, 20.4%; over-
weight, 12.7%) [1].
The FTO locus was first identified in a GWAS for type 2
diabetes in white Europeans, i.e. each minor allele
East Asians OR (95% CI) Weight (%)
WDS [35]
Chinese Hans (case=13,927, control=14,432)
1.37 (0.71, 2.63) 0.5
NHAPC [16]
CUHK [21]
SP2 [22]
0.90 (0.70, 1.15)
1.29 (1.06, 1.58)
0.73 (0.52, 1.02)
2.9
3.9
1.8
FLSGS [57]
Chang et al., 2008 [23]
1.16 (0.96, 1.40)
1.00 (0.83, 1.20)
4.2
4.4
SHDS [56]
Liu et al., 2010 [18]
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increased the odds of diabetes by 1.15-fold [1]. However,
after adjustment for BMI, the association between the FTO
variant and type 2 diabetes was completely abolished (OR
1.03), suggesting that FTO is primarily an obesity-
susceptibility locus [1]. In our meta-analysis, we observed
a similar effect of FTO on risk of type 2 diabetes, with each
minor allele increasing the odds by 1.15-fold. Interestingly,
adjustment for BMI did not abolish the association, but
only slightly attenuated it to a 1.10-fold increased risk of
type 2 diabetes for each additional minor allele. These
observations were similar in East and South Asians,
suggesting that the FTO locus influences the risk of type 2
diabetes, at least in part, independently of its effect on BMI.
The reason for the discrepancy between the original
observations in Europeans and our observations in
Asians are not known, but may be due to the fact that
FTO seems to have a smaller effect on BMI in Asians than
in Europeans. It may also be due to the fact that BMI, as
suggested above, represents a different adiposity pheno-
type in Asians than in Europeans because of differences in
body composition. Although BMI is a marker for general
adiposity, it does not distinguish between fat mass and fat-
free mass and does not reflect regional fat distribution.
Observational studies have suggested that, for a given
amount of total body fat, East and South Asians have more
abdominal fat and less muscle mass than white Europeans
[49, 50]. However, while it has been generally believed
that in white Europeans the association with type 2
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diabetes is fully mediated by the effect of FTO on BMI,
not all studies confirm this observation. A recent large-
scale study in 41,504 Scandinavians found that the FTO
minor allele indeed increased type 2 diabetes risk (OR
1.13), but this association remained present (OR 1.09)
after adjustment for BMI, consistent with the observations
in the present study. The biological pathways that underlie
the independent association between FTO variation with
obesity and type 2 diabetes remain unclear. However,
results of gene expression studies have shown that FTO
expression in human islets cells is not associated with
BMI [51], whereas FTO mRNA and protein levels in
muscle are increased in individuals with type 2 diabetes
compared with non-diabetic obese individuals or healthy
lean controls [52]. Furthermore, FTO overproduction in
myotubes suggested a role for FTO in oxidative metab-
olism, lipogenesis and oxidative stress in muscle, a
cluster of metabolic defects characteristic of type 2
diabetes [52].
Despite the fact that our meta-analyses included Asians
with different genetic backgrounds, the overall heterogeneity
of the association effects was generally only low to
moderate. Interestingly, we found that the associations
were generally very similar in East and South Asians,
although these populations are known to have geneti-
cally different origins [53]. Furthermore, we found no
differences between men and women, consistent with the
observations in white Europeans [7]. We found some
evidence that age may contribute to the heterogeneity of
the association between FTO and BMI. Life course effects
have been reported in white Europeans [54], and longitu-
dinal analyses will be needed to establish this in Asian
populations. Longitudinal studies are also more appropriate
than cross-sectional studies for disentangling the intricate
interplay between FTO, obesity and type 2 diabetes
throughout life [15].
It should be noted that the association between FTO
variation and obesity risk in Asians had been established in
three earlier meta-analyses [18, 29, 30]. These meta-
analyses were substantially smaller than the present ones
and focused solely on case–control analyses of obesity and
type 2 diabetes, while no continuous traits were studied.
The meta-analysis by Liu et al [18] included individuals of
East and South Asian origin, which were analysed together
without comparison of effect sizes between the two
populations. This study also examined the association with
type 2 diabetes, but did not explore the association after
adjustment for BMI [18]. Furthermore, the three previous
meta-analyses were all literature-based and thus more prone
to publication bias, whereas our meta-analysis was
designed on the basis of a de novo analysis of data
according to a standardised plan in all studies identified as
having available data and agreement to participate. No
evidence of publication bias was observed except for the
associations with BMI and hip circumference. The analyt-
ical consistency across studies helped minimise between-
study heterogeneity. Although our results are representative
of individuals of Southeast Asian, East Asian and South
Asian descent, the association of FTO with risk of obesity
and type 2 diabetes in other Asian populations remains to
be examined.
In summary, we have firmly established that genetic
variation in the first intron of FTO is associated with
increased risk of obesity and type 2 diabetes in Asians, with
effect sizes similar to those in Europeans. Furthermore, we
confirm that the association of FTO with risk of type 2
diabetes is partly independent of BMI.
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